Overview

Study of [14C]CS0159 in China Healthy Subjects

Status:
Completed
Trial end date:
2023-11-02
Target enrollment:
Participant gender:
Summary
Study of [14C]CS0159 in China Healthy Subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Cascade Pharmaceuticals, Inc